Medication Guide - 8/14/2026

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see FDA Online Label Repository or DailyMed for these Medication Guides). More

Drug Name	Active Ingredient	Form;Route	Appl. No.	Company	Date
Bonsity	Teriparatide	SOLUTION;SUBCUTANEOUS	211939	ALVOGEN	08/11/2026
Forteo	Teriparatide	SOLUTION;SUBCUTANEOUS	021318	LILLY	08/11/2026
Inpefa	Sotagliflozin	TABLET; ORAL	216203	LEXICON PHARMACEUTICALS	08/11/2026
Tymlos	Abaloparatide	SOLUTION;SUBCUTANEOUS	208743	RADIUS HEALTH INC	08/11/2026
Xolair	Omalizumab	VIAL	103976	GENENTECH	08/11/2026
Yorvipath	Palopegteriparatide	INJECTABLE;SOLUTION	216490	ASCENDIS PHARMA BONE DISEASES A/S	08/11/2026

Manage Subscriptions | Unsubscribe All | Help


This email was sent to Esdek@podam.pl using Granicus Communications Cloud on behalf of: U.S. Food and Drug Administration · 10903 New Hampshire Ave · Silver Spring, MD · 20993-0002 · 1-888-INFO-FDA